Get notified when ASPI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: ASPI ASP Isotopes Inc. 8-K

ASP Isotopes subsidiary signs Texas A&M research pact to advance uranium conversion tech

Filed July 21, 2026 · Period ending July 21, 2026 · ~1 min read

Key Changes

  • high

    Quantum Leap Energy (wholly-owned subsidiary) entered research agreement with Texas A&M Engineering Experiment Station to develop uranium conversion technology producing high-purity uranium hexafluoride from yellowcake uranium.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • high

    Research targets fundamental data on conversion reactions to improve efficiency, reduce costs, and support scale-up of domestic uranium conversion capabilities—critical given U.S. has only one operating commercial conversion facility.

    Exhibit 99.1 view on EDGAR →
  • medium

    Study aims to strengthen engineering basis for QLE's conversion technology commercialization and contribute to more resilient U.S. nuclear fuel supply chain by reducing foreign dependence.

    Exhibit 99.1 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FTHM 10-Q) is open in full — no account needed.

Partner

Trade ASPI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 22, 2026 · How we verify